These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
317 related articles for article (PubMed ID: 291480)
1. cis-Dichlorodiammineplatinum(II): combination chemotherapy and cross-resistance studies with tumors of mice. Schabel FM; Trader MW; Laster WR; Corbett TH; Griswold DP Cancer Treat Rep; 1979; 63(9-10):1459-73. PubMed ID: 291480 [TBL] [Abstract][Full Text] [Related]
2. Nitrosoureas: a review of experimental antitumor activity. Schabel FM Cancer Treat Rep; 1976 Jun; 60(6):665-98. PubMed ID: 782694 [TBL] [Abstract][Full Text] [Related]
3. Chemotherapy with [SP-4-3-(R)]-[1,1-cyclobutanedicarboxylato(2-)](2- methyl-1,4-butanediamine-N,N')platinum (CI-973, NK121) in combination with standard agents against murine tumors in vivo. Elliott WL; Roberts BJ; Howard CT; Leopold WR Cancer Res; 1994 Aug; 54(16):4412-8. PubMed ID: 8044790 [TBL] [Abstract][Full Text] [Related]
4. Combination chemotherapy with a new folate analog: activity of 10-ethyl-10-deaza-aminopterin compared to methotrexate with 5-fluorouracil and alkylating agents against advanced metastatic disease in murine tumor models. Schmid FA; Sirotnak FM; Otter GM; DeGraw JI Cancer Treat Rep; 1987; 71(7-8):727-32. PubMed ID: 3607784 [TBL] [Abstract][Full Text] [Related]
5. Establishment of cross-resistance profiles for new agents. Schabel FM; Skipper HE; Trader MW; Laster WR; Griswold DP; Corbett TH Cancer Treat Rep; 1983 Oct; 67(10):905-22. PubMed ID: 6354439 [TBL] [Abstract][Full Text] [Related]
6. Antitumor activity of a novel antitumor antibiotic, quinocarmycin citrate (KW2152). Fujimoto K; Oka T; Morimoto M Cancer Res; 1987 Mar; 47(6):1516-22. PubMed ID: 2434218 [TBL] [Abstract][Full Text] [Related]
7. Antitumor effects of three platinum complexes, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)-platinum (II) monohydrate (DWA2114R), cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) (CBDCA) and cis-diamminedichloroplatinum(II) (CDDP), in mice. Endo K; Akamatsu K; Matsumoto T; Morikawa K; Koizumi M; Mitsui H; Koizumi K Anticancer Res; 1992; 12(1):49-58. PubMed ID: 1567181 [TBL] [Abstract][Full Text] [Related]
8. Rationale for development of platinum analogs. Burchenal JH; Kalaher K; Dew K; Lokys L Cancer Treat Rep; 1979; 63(9-10):1493-8. PubMed ID: 498148 [TBL] [Abstract][Full Text] [Related]
9. Novel trans platinum complexes: comparative in vitro and in vivo activity against platinum-sensitive and resistant murine tumours. Goddard PM; Orr RM; Valenti MR; Barnard CF; Murrer BA; Kelland LR; Harrap KR Anticancer Res; 1996; 16(1):33-8. PubMed ID: 8615631 [TBL] [Abstract][Full Text] [Related]
10. Preclinical antitumor activity of bizelesin in mice. Carter CA; Waud WR; Li LH; DeKoning TF; McGovren JP; Plowman J Clin Cancer Res; 1996 Jul; 2(7):1143-9. PubMed ID: 9816280 [TBL] [Abstract][Full Text] [Related]
11. Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials. Thigpen T; Vance R; Puneky L; Khansur T Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S97-107. PubMed ID: 7835816 [TBL] [Abstract][Full Text] [Related]
12. Comparison of 5-fluorouracil and ftorafur. II. Therapeutic response and development of resistance in murine tumors. Garibjanian BT; Johnson RK; Kline I; Vadlamudi S; Gang M; Venditti JM; Goldin A Cancer Treat Rep; 1976 Sep; 60(9):1347-61. PubMed ID: 797450 [TBL] [Abstract][Full Text] [Related]
13. Response of transplantable tumors of mice to anthracenedione derivatives alone and in combination with clinically useful agents. Corbett TH; Roberts BJ; Trader MW; Laster WR; Griswold DP; Schabel FM Cancer Treat Rep; 1982 May; 66(5):1187-200. PubMed ID: 7083221 [TBL] [Abstract][Full Text] [Related]
14. Relationship between modulation of natural killer cell activity and antitumor activity of bropirimine when used in combination with various types of chemotherapeutic drugs. Li LH; DeKoning TF; Wallace TL Cancer Res; 1987 Nov; 47(22):5894-900. PubMed ID: 3664490 [TBL] [Abstract][Full Text] [Related]
15. Potentiation by vitamin A of the action of anticancer agents against murine tumors. Nakagawa M; Yamaguchi T; Ueda H; Shiraishi N; Komiyama S; Akiyama S; Ogata J; Kuwano M Jpn J Cancer Res; 1985 Sep; 76(9):887-94. PubMed ID: 3932288 [TBL] [Abstract][Full Text] [Related]
16. [Combination therapy of a new platinum complex, DWA2114R with various antitumor agents against mouse tumors in vivo]. Akamatsu K; Endo K; Tsunenari T; Matsumoto T; Kaiho S; Morikawa K; Koizumi M; Mitsui H; Koizumi K Gan To Kagaku Ryoho; 1992 Feb; 19(2):229-35. PubMed ID: 1736835 [TBL] [Abstract][Full Text] [Related]
17. Synergistic effects of the combination of cis-platinum diamminodichloride and 2,2'-anhydro-1-beta-D-arabinofuranosyl-5-fluorocytosine in transplanted mouse leukemias. Burchenal JH; O'Toole T; Kalaher K; Chisholm J Cancer Res; 1977 Nov; 37(11):4098-100. PubMed ID: 71204 [TBL] [Abstract][Full Text] [Related]
18. Antitumor activity of 2-chloroethyl (methylsulfonyl)methanesulfonate (clomesone, NSC 33847) against selected tumor systems in mice. Dykes DJ; Waud WR; Harrison SD; Laster WR; Griswold DP; Shealy YF; Montgomery JA Cancer Res; 1989 Mar; 49(5):1182-6. PubMed ID: 2537144 [TBL] [Abstract][Full Text] [Related]
19. Resistance patterns of Walker carcinosarcoma 256 and other rodent tumors to cyclophosphamide and L-phenylalanine mustard. Schmid FA; Otter GM; Stock CC Cancer Res; 1980 Mar; 40(3):830-3. PubMed ID: 7471099 [TBL] [Abstract][Full Text] [Related]
20. L-histidinol: preclinical therapeutic studies in combination with antitumor agents and pharmacokinetic studies in mice. Zaharko D; Plowman J; Waud W; Dykes D; Malspeis L Cancer Res; 1992 Jul; 52(13):3604-9. PubMed ID: 1617631 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]